News

Novo Nordisk Q1 Earnings Review: Forget Revenue Miss, Buy Semaglutide Hype
Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...
Rheumatology Advisor8h
Semaglutide Beneficial in Metabolic Dysfunction-Associated Steatohepatitis, Fibrosis
For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes.
Can Ozempic reverse liver disease? New study holds the answer
Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...
Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025
Financial report for the period 1 January 2025 to 31 March 2025 Operating profit increased by 22% in Danish kroner and by 20% ...
The Zacks Analyst Blog Highlights Novo Nordisk, Honeywell International and American Tower
Detailed price information for American Tower Corp (AMT-N) from The Globe and Mail including charting and trades.
Health and Me on MSN16h
Ozempic Reverses Liver Diseases, New Study Finds
A new study published in the New England Journal Of Medicine claimed that it can tackle non-alcoholic steatohepatitis or NASH ...
Investor's Business Daily on MSN1h
Novo Nordisk Blames Compounders As It Cuts 2025 Forecast. But Shares Jump.
Novo Nordisk stock jumped early Wednesday despite cutting its 2025 outlook due to what Novo says is illegal compounding of ...
Top Analyst Reports for Novo Nordisk, Honeywell & American Tower
Detailed price information for American Tower Corp (AMT-N) from The Globe and Mail including charting and trades.